tirzepatide anthem blue cross Blue Shield of Michigan GLP-1 Coverage Changes Explained — Restorative Compounding Pharmacy + Wellness Why we are changing coverage
Description
A phase 2 trial finds that combining semaglutide with bimagrumab leads to greater weight loss while preserving lean mass, highlighting the importance of body composition in obesity treatment.
Look & feel fantastic!
Semaglutide is a type of glucagon-like peptide-1 (GLP-1) receptor agonist, which works by mimicking the effects of the naturally occurring hormone GLP-1 in the body
A major limitation was that it was done exclusively among U.S
Zepbound was approved by the FDA for weight loss in November.
Call us in Washington, D.C., to schedule a free consultation today.
